These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35406531)

  • 1. Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine.
    Seguin L; Durandy M; Feral CC
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
    Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
    Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.
    Melocchi V; Dama E; Mazzarelli F; Cuttano R; Colangelo T; Di Candia L; Lugli E; Veronesi G; Pelosi G; Ferretti GM; Taurchini M; Graziano P; Bianchi F
    Oncogene; 2021 Aug; 40(31):4980-4991. PubMed ID: 34172935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung Adenocarcinoma.
    He Y; Liu X; Wang H; Wu L; Jiang M; Guo H; Zhu J; Wu S; Sun H; Chen S; Zhu Y; Zhou C; Yang Y
    Small Methods; 2021 Jun; 5(6):e2100082. PubMed ID: 34927899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma.
    Xu JZ; Gong C; Xie ZF; Zhao H
    Front Oncol; 2020; 10():593022. PubMed ID: 33585210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A detrimental mutation on USP40 unlocks the tumorigenesis in a rare case of lung cancer.
    Xu ZH; Wang H; Ji XY; Zhang FX; Gao BL; Hu JA; Zheng J
    Int J Clin Exp Pathol; 2019; 12(3):740-749. PubMed ID: 31933881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
    Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Role of Arrhythmia-Related Gene
    Chang KT; Wu HJ; Liu CW; Li CY; Lin HY
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.
    Abe M; Watanabe K; Shinozaki-Ushiku A; Ushiku T; Abe T; Fujihara Y; Amano Y; Zong L; Wang CP; Kubo E; Inaki R; Kinoshita N; Yamashita S; Takai D; Ushijima T; Nagase T; Hoshi K
    BMC Cancer; 2019 Jan; 19(1):52. PubMed ID: 30634950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung Tumorigenesis.
    O'Farrell H; Harbourne B; Kurlawala Z; Inoue Y; Nagelberg AL; Martinez VD; Lu D; Oh MH; Coe BP; Thu KL; Somwar R; Lam S; Lam WL; Unni AM; Beverly L; Lockwood WW
    J Thorac Oncol; 2019 Apr; 14(4):656-671. PubMed ID: 30578931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive evidence for Club cells as progenitors for mutant Kras/Trp53-deficient lung cancer.
    Rosigkeit S; Kruchem M; Thies D; Kreft A; Eichler E; Boegel S; Jansky S; Siegl D; Kaps L; Pickert G; Haehnel P; Kindler T; Hartwig UF; Guerra C; Barbacid M; Schuppan D; Bockamp E
    Int J Cancer; 2021 Nov; 149(9):1670-1682. PubMed ID: 34331774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupled immune stratification and identification of therapeutic candidates in patients with lung adenocarcinoma.
    Hu W; Wang G; Chen Y; Yarmus LB; Liu B; Wan Y
    Aging (Albany NY); 2020 Aug; 12(16):16514-16538. PubMed ID: 32855362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high expression of miR-31 in lung adenocarcinoma inhibits the malignancy of lung adenocarcinoma tumor stem cells.
    Xu R; Liu T; Zuo L; Guo D; Ye G; Jiang J; Yu X; Zhang S; Hou C
    Biochem Biophys Rep; 2021 Dec; 28():101122. PubMed ID: 34485716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.
    Cheng WC; Chang CY; Lo CC; Hsieh CY; Kuo TT; Tseng GC; Wong SC; Chiang SF; Huang KC; Lai LC; Lu TP; Chao KSC; Sher YP
    Theranostics; 2021; 11(8):3661-3675. PubMed ID: 33664854
    [No Abstract]   [Full Text] [Related]  

  • 20. Flotilin-1 promotes the tumorigenicity and progression of malignant phenotype in human lung adenocarcinoma.
    Guo AY; Liang XJ; Liu RJ; Li XX; Bi W; Zhou LY; Tang CE; Yan A; Chen ZC; Zhang PF
    Cancer Biol Ther; 2017 Sep; 18(9):715-722. PubMed ID: 28825855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.